Latest Administration News

AnteoTech Ltd has completed a strategic review that refocuses its business on commercialising existing products, delivering $1.6 million in annual cost savings and expanding its sales pipeline in battery and life sciences markets.

Argenica Therapeutics faces a clinical hold from the US FDA on its stroke drug trial application, though its Australian Phase 2 study remains unaffected and on track.

Firebrick Pharma has published its pivotal Phase 3 trial results for Nasodine nasal spray, confirming its effectiveness and safety in treating the common cold, especially when used early.

Solis Minerals is set to delist from the TSX Venture Exchange, consolidating its primary listing on the ASX and planning a re-domiciliation to Australia to sharpen its focus on copper-gold exploration in Peru.

Vection Technologies has launched its Algho AI Sign Language solution on Amazon Web Services Marketplace, targeting enhanced accessibility across Europe. Early contracts signal strong market interest in AI-driven communication tools for the Deaf and hard-of-hearing community.

Vinyl Group Ltd has obtained an amended Federal Court order correcting a minor share count error in a previous ruling and secured relief from civil liability related to cleansing notice delays, prompting a request to lift its trading suspension.

Beacon Minerals Limited has announced plans for a significant 40-for-1 consolidation of its shares and options, pending shareholder approval in July 2025. This move aims to streamline the capital structure and adjust option exercise prices accordingly.

Toys’R’Us ANZ Limited has been suspended from ASX trading following the appointment of voluntary administrators, signaling serious financial distress. The suspension will remain until the company meets ASX’s compliance requirements.

Toys’R’Us ANZ Limited has appointed voluntary administrators after abandoning its recapitalisation efforts, with ASX trading suspended immediately. The company aims to explore restructuring or sale options while maintaining operations.

Clarity Pharmaceuticals reports that its Cu-SARTATE diagnostic agent significantly outperforms the current standard in detecting neuroendocrine tumours, paving the way for a pivotal Phase III study.

Thunderbird Resources has entered a strategic option agreement with Mustang Energy, enabling Mustang to acquire up to 80% of two promising uranium projects in Canada’s Athabasca Basin while Thunderbird sharpens its focus on gold-antimony assets in New South Wales.

PainChek has advanced its US regulatory approval process with a positive FDA meeting, setting the stage for a potential market debut of its pain assessment app in late 2025.